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Table 1
Clinically Significant Telomeric Aberrations Detected Using
Telomere Region–Specific FISH Probes
Telomeric Aberration
No.
Observed Probe(s) Used
ish del(1)(qter) 1 PAC 160H23
ish der(2)t(2q;17q)pat 1a P1 210E14, cosmid B37c1
ish der(18)t(7p;18q)mat 1 PAC 164D18, PAC 964M9
ish der(22)t(14q;22p)mat 1 PAC 820M16, D14Z1/D22Z1b
a Source: Bacino et al. (2000).
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The Promise and Pitfalls of Telomere Region–Specific
Probes
To the Editor:
A complete set of telomere region–specific FISH probes
designed to hybridize to the unique subtelomeric regions
of every human chromosome was initially described in
1996 (National Institutes of Health et al. 1996), and an
update was recently reported in the Journal (Knight et
al. 2000). It was anticipated that these probes would be
extremely valuable in the identification of submicro-
scopic telomeric aberrations that were thought to ac-
count for a substantial yet previously underrecognized
proportion of cases of mental retardation in the popu-
lation. Recently, a version of these probes was made
commercially available as part of a diagnostic device that
allows for simultaneous analysis of the telomeric regions
of every human chromosome, except the p arms of the
acrocentric chromosomes, on a single microscope slide
(Cytocell) (Knight et al. 1997). The utility of these
probes is evident in that numerous reports now exist
describing cryptic telomere rearrangements or submi-
croscopic telomeric deletions that were undetectable by
standard cytogenetic banding techniques but that were
revealed by these FISH probes (Horsley et al. 1998; Ballif
et al. 2000; reviewed in Knight and Flint 2000). Fur-
thermore, several recent studies that have used these
probes to investigate the telomeric regions of patients
who have idiopathic mental retardation with apparently
normal karyotypes indicate that 23% of such cases
have cryptic telomeric aberrations (Knight et al. 1999;
reviewed in Knight and Flint 2000). This suggests that
telomeric anomalies may be second only to Down syn-
drome as the most common cause of mental retardation
(Knight and Flint 2000).
In our clinical cytogenetics laboratory, we have used
telomere region–specific probes to examine the telomeric
regions of 154 unrelated patients with apparently nor-
mal karyotypes, submitted for a variety of clinical in-
dications. The recent report, in the Journal, by Knight
et al. (2000) prompted us to examine the results, to date,
of our telomeric FISH assay. This is not a controlled
study of a selected population but, rather, a glance at
the telomeric anomalies identified since the inception of
the telomeric assay in the laboratory. Metaphase chro-
mosomes obtained from peripheral blood specimens sent
by the referring physician were analyzed in all cases. Of
these patients, 15/154 (9.7%) had either submicroscopic
telomeric deletions or cryptic telomeric rearrangements
identified. However, only 4/15 (27%) telomeric abnor-
malities were shown to potentially contribute to the phe-
notype, since 11/15 (73%) patients inherited apparently
benign telomeric variants from a phenotypically normal
parent who carried the same cytogenetic “anomaly” (fig.
1). This reduces the percentage of clinically significant
subtelomeric aberrations to 4/154 (2.6%) in our study
population.
The four clinically significant telomeric abnormalities
are listed in table 1. Patients included in this study un-
derwent diagnostic study because of a variety of clinical
indications, including developmental delay, mental re-
tardation, dysmorphic features, and/or multiple congen-
ital anomalies. However, the precise details of the clinical
diagnoses were not available to the diagnostic labora-
tory, which limited further extrapolation of these telo-
meric abnormalities being associated with a particular
phenotype or subset of patients. All 11 observed telo-
meric polymorphisms are listed in table 2. Our data
indicate that telomeric polymorphisms may be quite
common (occurring in ∼7% of patients studied), with
a deletion in the 2q subtelomeric region occurring in
8/154 patients (∼5% of the population). By means of a
cosmid (2112b2), this 2q polymorphism has been de-
tected elsewhere (Knight and Flint 2000; Knight et al.
2000). However, it was noted that the 2q probe present
on the commercial telomere device had been recently
updated, by the manufacturer, to a PAC probe (Genome
Systems PAC 1011O17). Although the updated probe is
larger than the first-generation cosmid used and is lo-
cated !240 kb from the true telomere, it still detects the
polymorphism (fig. 1A and B) (Knight and Flint 2000;
Knight et al. 2000). For those patients who show a 2q
deletion with PAC 1011O17, FISH using another ver-
sion of the 2q probe (P1 210E14) (National Institutes
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Table 2
Telomeric Polymorphisms Detected Using Telomere Region–Specific
FISH Probes
Telomeric Polymorphism
No.
Observed Probe(s) Used
ish add(1)(qter)(13qtel)pat 1a PAC 163C9
ish del(2)(qter)mat or pat 8 PAC 1011O17, P1 210E14b
ish del(9)(pter)pat 1 PAC 43N6
ish del(X)(pter)pat 1 Cosmid CY29
a Source: Shaffer et al. (1999).
b PAC 1011O17 was deleted in all patients, and P1 210E14 was
not deleted in all patients.
of Health et al. 1996; Knight et al. 1997) demonstrated
signals on both chromosomes, indicating nondeletion of
this locus (data not shown). Although the parents of
three patients with 2q deletions were unavailable for
study, these patients showed the presence of the previ-
ously reported 2q subtelomeric probe (P1 210E14) on
both homologues, making it highly likely that the anom-
alies seen in these patients also represent 2q polymor-
phisms. In addition, the XpYp subtelomeric cosmid
probe (CY29), designed to hybridize to the pseudoau-
tosomal regions of both sex chromosomes, has been
shown to detect polymorphic sequences (Knight and
Flint 2000; Knight et al. 2000), as found in one of our
cases (fig. 1C). Detection of a 9pter polymorphism by
telomere region–specific probes has not been previously
reported (fig. 1D). It is expected that, as the limits of
the technology are pushed farther toward the ends of
the chromosome, more polymorphisms are likely to be
identified.
The American College of Medical Genetics, in con-
junction with the College of American Pathologists,
has set forth guidelines for validation of FISH probes
(Watson 1999). These guidelines suggest hybridizing five
normal specimens with each new FISH probe. This ap-
proach will not uncover the frequency of these subte-
lomeric polymorphisms, and large numbers of normal
individuals need to be tested to gather the frequencies
of these polymorphic variants in the population. Al-
though identifying these polymorphisms and the fre-
quency with which they occur may help in the under-
standing of telomere structure and function, as well as
in the understanding of the mechanisms that underlie
the formation of terminal deletions and subtelomeric re-
arrangements, polymorphic subtelomeric probes are ten-
uous for diagnostic purposes. Whenever possible, when
abnormalities are observed, parental samples should be
tested with the same telomere region–specific probes,
prior to the interpretation of the results from the child,
to exclude the possibility of a benign familial polymor-
phism segregating in the family (Shaffer et al. 1999).
This approach will improve the usefulness of these
probes in the identification of telomeric alterations with
true clinical significance.
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probes specific for q arms fluoresce red. A, Metaphase from a phenotypically normal parent, showing a deletion of the 2q telomere region–specific
FISH probe (arrow). Note a normal hybridization pattern for the 2p telomere region–specific FISH probe. B, Metaphase from the child of the
parent shown in A, indicating an inherited deletion of the 2q FISH probe (arrow). C, Metaphase from a patient with a polymorphic deletion
of the Xp subtelomeric probe (arrow) that was paternally inherited (parental data not shown). D, Metaphase from a patient showing a
polymorphic deletion, of the 9p FISH probe (arrow), that was paternally inherited (parental data not shown).
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